BR0008557A - Emprego de sistemas policìclicos de 2-amino-tiazolpara a preparação de medicamentos para aprofilaxia ou tratamento da obesidade - Google Patents

Emprego de sistemas policìclicos de 2-amino-tiazolpara a preparação de medicamentos para aprofilaxia ou tratamento da obesidade

Info

Publication number
BR0008557A
BR0008557A BR0008557-0A BR0008557A BR0008557A BR 0008557 A BR0008557 A BR 0008557A BR 0008557 A BR0008557 A BR 0008557A BR 0008557 A BR0008557 A BR 0008557A
Authority
BR
Brazil
Prior art keywords
treatment
obesity
aprophylaxis
thiazole
drugs
Prior art date
Application number
BR0008557-0A
Other languages
English (en)
Inventor
Gerhard Jaehne
Karl Geisen
Hans-Jochen Lang
Martin Bickel
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of BR0008557A publication Critical patent/BR0008557A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Patente de invenção: "EMPREGO DE SISTEMAS POLICìCLICOSDE 2-AMINO-TIAZOL PARA A PREPARAçãO DEMEDICAMENTOS PARA A PROFILAXIA OU TRATAMENTO DAOBESIDADE". A invenção refere-se ao emprego de sistemaspolicíclicos de 2-amino-tiazol, bem como de seus saisfisiologicamente compatíveis e derivados fisiologicamentefuncionais. é descrito o emprego dos compostos da fórmula I, emque os radicais possuem os significados dados, bem como de seussais fisiologicamente compatíveis e derivados fisiologicamentefuncionais para a preparação de um medicamento para a profilaxiaou tratamento da obesidade.
BR0008557-0A 1999-02-26 2000-02-05 Emprego de sistemas policìclicos de 2-amino-tiazolpara a preparação de medicamentos para aprofilaxia ou tratamento da obesidade BR0008557A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19908537A DE19908537A1 (de) 1999-02-26 1999-02-26 Verwendung von polycyclischen 2-Amino-Thiazol Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
PCT/EP2000/000925 WO2000051602A1 (de) 1999-02-26 2000-02-05 Verwendung von polycyclischen 2-amino-thiazol systemen zur herstellung von medikamenten zur prophylaxe oder behandlung von obesitas

Publications (1)

Publication Number Publication Date
BR0008557A true BR0008557A (pt) 2001-12-18

Family

ID=7899081

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0008557-0A BR0008557A (pt) 1999-02-26 2000-02-05 Emprego de sistemas policìclicos de 2-amino-tiazolpara a preparação de medicamentos para aprofilaxia ou tratamento da obesidade

Country Status (16)

Country Link
US (1) US6476059B1 (pt)
EP (1) EP1173176B1 (pt)
JP (1) JP4728483B2 (pt)
KR (1) KR20020002394A (pt)
CN (1) CN1161120C (pt)
AT (1) ATE267597T1 (pt)
AU (1) AU766295B2 (pt)
BR (1) BR0008557A (pt)
CA (1) CA2362554A1 (pt)
DE (2) DE19908537A1 (pt)
DK (1) DK1173176T3 (pt)
ES (1) ES2218122T3 (pt)
HK (1) HK1045809B (pt)
PT (1) PT1173176E (pt)
WO (1) WO2000051602A1 (pt)
ZA (1) ZA200106199B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19908538A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Thiazol Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
WO2000064880A1 (en) * 1999-04-22 2000-11-02 Synaptic Pharmaceutical Corporation Selective npy (y5) antagonists
WO2001064675A1 (en) * 2000-03-03 2001-09-07 Novartis Ag Condensed thiazolamines and their use as neuropeptide y5 antagonists
EP1305023A4 (en) * 2000-08-01 2005-02-23 Univ Virginia USE OF SELECTIVE AGONISTS, ANTAGONISTS AND ALLOSTERIC AMPLIFIERS OF THE ADENOSINE A1 RECEPTOR TO INFLUENCE THE ANGIOGENESIS
WO2003061655A1 (en) * 2002-01-16 2003-07-31 University Of Virginia Patent Foundation 2-aminothiazole allosteric enhancers of a1 adenosine receptors
US20060166957A1 (en) * 2003-06-12 2006-07-27 Menachem Rubinstein Methods of treating obesity and related disorders using tellurium selenium compounds
AU2005268899B2 (en) 2004-08-05 2009-09-24 F. Hoffmann-La Roche Ag Substituted N-acyl-2-aminothiazoles
WO2006080406A1 (ja) * 2005-01-28 2006-08-03 Taisho Pharmaceutical Co., Ltd. 三環性化合物
CL2009000780A1 (es) 2008-03-31 2010-01-15 Genentech Inc Compuestos derivados de heterociclil-pirano-heterociclilo, heterociclil-oxepina-heterociclilo, benzopirano-heterociclilo y benzoxepina-heterociclilo sustituidos; composicion farmaceutica; procedimiento de preparacion de la composicion; kit farmaceutico; y su uso en el tratamiento del cancer, mediado por la inhibicion de pi3k.
KR101449217B1 (ko) * 2009-09-28 2014-10-08 에프. 호프만-라 로슈 아게 벤즈옥세핀 ｐｉ3ｋ 억제제 화합물 및 사용 방법
ES2570569T3 (es) 2009-09-28 2016-05-19 Hoffmann La Roche Compuestos de benzoxazepina como inhibidores de la PI3K y métodos de uso
RU2013143747A (ru) 2011-03-21 2015-04-27 Ф. Хоффманн-Ля Рош Аг Соединения бензоксазепина, селективные в отношении pi3k p110 дельта и способы их применения

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507868A (en) * 1968-10-21 1970-04-21 Sandoz Ag Imidazo(2,1-b)thiazoles and thiazolo(3,2-a)pyrimidines
DE2640358A1 (de) * 1976-09-08 1978-03-16 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
JPS5334471A (en) * 1976-09-10 1978-03-31 Toshiba Corp Manufacture for semiconductor device
CA1292226C (en) * 1986-01-16 1991-11-19 Terumi Hachiya Indenothiazole derivative and process for preparing the same
IE68593B1 (en) * 1989-12-06 1996-06-26 Sanofi Sa Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them
DE19831878C2 (de) * 1998-07-17 2001-05-17 Aventis Pharma Gmbh Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908538A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Thiazol Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen

Also Published As

Publication number Publication date
DK1173176T3 (da) 2004-09-27
KR20020002394A (ko) 2002-01-09
CA2362554A1 (en) 2000-09-08
JP4728483B2 (ja) 2011-07-20
ES2218122T3 (es) 2004-11-16
HK1045809B (zh) 2005-04-22
ATE267597T1 (de) 2004-06-15
ZA200106199B (en) 2002-03-06
EP1173176B1 (de) 2004-05-26
AU766295B2 (en) 2003-10-16
WO2000051602A1 (de) 2000-09-08
AU2670300A (en) 2000-09-21
DE19908537A1 (de) 2000-08-31
DE50006603D1 (de) 2004-07-01
HK1045809A1 (en) 2002-12-13
US6476059B1 (en) 2002-11-05
EP1173176A1 (de) 2002-01-23
JP2002538117A (ja) 2002-11-12
CN1161120C (zh) 2004-08-11
PT1173176E (pt) 2004-09-30
CN1349404A (zh) 2002-05-15

Similar Documents

Publication Publication Date Title
MY137039A (en) Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
WO2004067550A3 (fr) Nouvelle utilisation de la mifepristone et de ses derives comme modulateurs de la voie de signalisation des proteines hedgehog et ses applications
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
BR0208678A (pt) Composto, composição farmacêutica, uso de um composto
BR0109703A (pt) Derivados de piperazina
BRPI0410170A (pt) preparação e uso de derivados de ácido aril alquìlico para o tratamento de obesidade
BR0008557A (pt) Emprego de sistemas policìclicos de 2-amino-tiazolpara a preparação de medicamentos para aprofilaxia ou tratamento da obesidade
ATE307819T1 (de) Curcumin-derivate mit gegenüber curcumin verbesserter wasserlöslichkeit und diese enthaltende arzneimittel
NO20063277L (no) Farmasoytisk sammensetning av vinflunin som er ment for parenteral administrering, fremstillingsmate og anvendelse derav
PT1212312E (pt) Novos derivados de flavonas xantonas e cumarinas
BR0008519A (pt) Aplicação de sistemas tiazol policìclicos para apreparação de medicamentos para a profilaxia outratamento da obesidade
GEP20053617B (en) Bridged Piperazine Derivatives
BRPI0410986A (pt) derivados de estaurosporina para sìndrome hipereosinofìlica
PT1157015E (pt) Utilizacao de sistemas 2-amino-triazole policiclicos para a preparacao de medicamentos para tratamento de perturbacoes lipometabolicas, da obesidade e da diabetes tipo ii
MXPA04001847A (es) Uso de sistemas de indan-1-ol polisbstituidos para producir drogas utilizadas en la profilaxis o tratamiento de la obesidad.
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
ATE296295T1 (de) Polycyclische thiazol-systeme und ihre verwendung als anorektika
BR0210910A (pt) Derivados de imidazotriazinonas e sua aplicação contra processos inflamatórios e/ou doenças imunes
NO20021337D0 (no) 4-benzylaminoquinolinkonjugater med gallesyre og deres heteroanaloger, fremgangsmåte for deres fremstilling, legemidlersom inneholder disse forbindelser og deres anvendelse
PE20030335A1 (es) Utilizacion de sistemas de indan-1-ol-sustituidos en c2 para la preparacion de medicamentos para la profilaxia o el tratamiento de la obesidad
BR0008559A (pt) Aminas tiazol-2-ilideno policìclicas, processos paraa sua preparação e seu emprego comomedicamento
PT1263444E (pt) Aplicacao de derivados de xantina para a preparacao de um medicamento destinado a prevencao ou ao tratamento da osteoporose
PE20010752A1 (es) Uso de desloratadina para el tratamiento de estados alergicos e inflamatorios
HUP0203412A2 (hu) Kinazolinszármazékok és azok alkalmazása az AKT protein kináz rendszer aktiválására és/vagy az NFKB transzkripciós faktor gátlására alkalmas gyógyászati készítmény előállítására

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A, 8A E 9A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI2003 DE 26/05/2009.